The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS

NCT04651855 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Mesenchymal stem cells isolated from Wharton's jelly

Sponsor

Polski Bank Komorek Macierzystych JSC (PBKM)

Collaborators

[object Object]